Plus LibraryBy pinki@katapult.biz / February 13, 2025 Speciality — Amyotrophic Lateral Sclerosis (ALS) Biomarkers Biosimilars Bladder Blood Bone Brain Breast Cancer Central Nervous System (CNS) Clinical Trials Colon Colorectal Diversity, Equity & Inclusion Featured Content Gastrointestinal Genitourinary Genomic Geriatric Gynecology Head and Neck Hematologic Hematologic Maglinencies Hematology Immunotherapy Interventional Radiology Kidney Leukemia Liquid Biopsy Liver Lung Lymphoma Malignencies Melanoma Myelodysplastic Syndrome Myeloma Neuroendocrine Novel Oral & Maxillofacial Surgery Ovarian Pancreas Pancreatic Pharmacological Prostate Radiation Radiology Renal Sarcoma Skin Solid Tumor Supportive & Palliative Care Survivorship Telemedicine Thoracic Thrombosis Thymic Thyroid Urothelial Author / Speaker Title of Presentation Type of Media — Video Document Audio Event 2024 Event — 2024 California Cancer Consortium Conference (CCC) 2024 MLS Cleveland 2024 MLS Nashville 2024 MLS New Orleans 2024 MLS Seattle 2024 New Orleans Summer Cancer Meeting (NOSCM) 2024 PRIMO 2024 SPS Puerto Rico 2024 SPS Seattle 2024 SPECTRUM 2024 Sylvester APP Oncology Symposium 2024 WCS 2024 MaTOS Lungs 2025 PRIMO Clear Displaying 2,826 - 2,850 of 2,875 « 1 … 112 113 114 115 » Artificial Intelligence-Aided Lung Biopsy: Proof-of-Concept in Percutaneous Needle Pathway Selection Meridith Kisting, MA View PDF Telemedicine in Oncology Nate Gross, MD View PDF Telemedicine in Oncology Nate Gross, MD View Video Artificial Intelligence in Cancer Therapeutics: Fact or Fiction? Sanjay Juneja, MD Testicular Cancer: The Old, The New, The Future Pasquale W. Benedetto, MD View PDF Testicular Cancer: The Old, The New, The Future Pasquale W. Benedetto, MD View Video Strategies to Target Minimal Residual Disease Christine M. Lovly, MD, PhD View PDF Strategies to Target Minimal Residual Disease Christine M. Lovly, MD, PhD View Video MRD to Decide Perioperative Management in the Era of Immuno-Oncology Fred Hirsch, MD View PDF MRD to Decide Perioperative Management in the Era of Immuno-Oncology Fred Hirsch, MD View Video Immunotherapy Related Adverse Reactions Helen Shih, NP, MPH View PDF Immune-Related Adverse Events (irAE) Checkpoint Inhibitors Helen Shih, NP, MPH View PDF ALK-Altered Non-Squamous NSCLC Options and Sequence Jacob Sands, MD View PDF Neoadjuvant Treatment in Thoracic Surgery Jae Kim, MD View PDF Systemic Therapies for Mesothelioma Jorge E. Gomez, MD View PDF Systemic Therapies for Mesothelioma Jorge E. Gomez, MD View Video ALK Mutant NSCLC Lyudmila Bazhenova, MD View Video Oncogene-Driven NSCLC Matthew Gubens MD View PDF What Lies Beyond EGFR, ALK And ROS1 Targeted Therapies? Melissa L Johnson, MD View Video Squamous Cell Carcinoma Standard and Novel Targets Mohamed K Mohamed, MD, PhD View Video Squamous Cell Carcinoma Standard and Novel Targets. Mohamed K. Mohamed, MD, PhD View PDF Minimal Residual Disease (MRD) as Detected by Liquid Biopsy: Where are We Going? Natasha Leighl, MD View PDF Minimal Residual Disease (MRD) as Detected by Liquid Biopsy: Where are We Going? Natasha Leighl, MD View Video EGFR Mutations: What's Next? Natasha Leighl, MD, FASCO, FRCPS, MMSc View Video Role of SHP2 Inhibitors Alone or in Combination Rachel Sanborn, MD View PDF Post navigation ← Previous ViewNext View →
